These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15847680)

  • 1. Human physiologically based pharmacokinetic model for propofol.
    Levitt DG; Schnider TW
    BMC Anesthesiol; 2005 Apr; 5(1):4. PubMed ID: 15847680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.
    Levitt DG
    BMC Res Notes; 2009 Aug; 2():158. PubMed ID: 19656378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.
    Levitt DG
    BMC Anesthesiol; 2002 Aug; 2(1):5. PubMed ID: 12182764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.
    Levitt DG
    BMC Clin Pharmacol; 2004 Feb; 4():2. PubMed ID: 15053829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
    Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
    Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of the interstitial space in humans.
    Levitt DG
    BMC Clin Pharmacol; 2003 Jul; 3():3. PubMed ID: 12890292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKQuest: PBPK modeling of highly lipid soluble and extracellular solutes.
    Levitt DG
    ADMET DMPK; 2019; 7(1):60-75. PubMed ID: 35350744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
    Levitt DG; Schoemaker RC
    BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.
    Levitt DG
    BMC Clin Pharmacol; 2003 Mar; 3():1. PubMed ID: 12659643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human adipose blood flow.
    Levitt DG
    BMC Clin Pharmacol; 2007 Jan; 7():1. PubMed ID: 17239252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.
    Levitt DG
    BMC Clin Pharmacol; 2002 Aug; 2():5. PubMed ID: 12182760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of PBPK modeling across the pediatric age range using propofol as a case.
    Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKQuest: capillary permeability limitation and plasma protein binding - application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics.
    Levitt DG
    BMC Clin Pharmacol; 2002 Sep; 2():7. PubMed ID: 12323078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep.
    Craigmill AL
    J Vet Pharmacol Ther; 2003 Feb; 26(1):55-63. PubMed ID: 12603776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach for incorporating tissue composition data into physiologically based pharmacokinetic models.
    Pelekis M; Poulin P; Krishnan K
    Toxicol Ind Health; 1995; 11(5):511-22. PubMed ID: 8677516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.
    Diestelhorst C; Boos J; McCune JS; Russell J; Kangarloo SB; Hempel G
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):991-1000. PubMed ID: 24061863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].
    Sepúlveda PO; Mora X
    Rev Esp Anestesiol Reanim; 2012 Dec; 59(10):542-8. PubMed ID: 23040653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.